Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Jul;26(7):1248-1256.
doi: 10.1007/s10147-021-01909-9. Epub 2021 Jun 5.

Benefit of intensive chemotherapy for elderly patients aged 80 years or older with metastatic colorectal cancer: a state-wide multicenter cohort study

Yujiro Nakayama  1   2 , Hidetaka Kawamura  3   4 , Michitaka Honda  3   4 , Yoshinao Takano  4 , Koichi Takiguchi  5 , Takahiro Kamiga  6 , Shigeru Yamazaki  7 , Atsushi Muto  8 , Satoru Shiraso  9 , Naoyuki Yamashita  10 , Toshiyasu Iwao  11 , Koji Kono  12 , Shinichi Konno  13
Affiliations
Multicenter Study

Benefit of intensive chemotherapy for elderly patients aged 80 years or older with metastatic colorectal cancer: a state-wide multicenter cohort study

Yujiro Nakayama et al. Int J Clin Oncol. 2021 Jul.

Abstract

Background: It remains unclear whether intensive chemotherapy for Stage IV colorectal cancer (CRC) patients aged 80 years or older is beneficial prognostically. This study aimed to investigate the overall survival of Stage IV CRC patients aged ≥ 80 years receiving intensive chemotherapy.

Methods: The study design was a population-based, multicenter, historical cohort study. The extracted participants' data were consecutive patients diagnosed as Stage IV CRC between January 2008 and May 2015 in nine hospitals in Japan. Patients were classified into two groups according to age: aged group (≥ 80 years) and younger group (< 80 years old). Intensive chemotherapy was defined as at least two courses of doublet chemotherapy with oxaliplatin-or irinotecan-based regimens. The primary outcome was the adjusted hazard ratio (HR) of age ≥ 80 years in patients who undergoing intensive chemotherapy.

Results: During the study period, 1259 patients were treated for Stage IV CRC in the participating hospitals. In total, 231 patients (18.3%) were in the aged group, and 1028 (81.7%) were in the younger group, and 788 (62.6%) underwent intensive chemotherapy. The median overall survival for the aged and younger group patients was 21.0 months (interquartile range (IQR), 10.6-34.1 months) and 24.3 months (IQR 12.6-39.3 months), respectively. The adjusted HR of age ≥ 80 years was 1.29 (confidence intervals 0.84-2.00).

Conclusion: Stage IV CRC patients aged 80 years or older receiving intensive chemotherapy had a similar prognosis to those aged < 80 years. Avoiding intensive chemotherapy for mCRC patients simply because they are ≥ 80 years old is not recommended.

Keywords: Aged 80 and over; Chemotherapy; Colorectal cancer; Elderly patient.

PubMed Disclaimer

References

    1. Van Cutsem E, Cervantes A, Adam R et al (2016) ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol 27:1386–1422. https://doi.org/10.1093/annonc/mdw235 - DOI - PubMed
    1. Sorbye H, Cvancarova M, Qvortrup C et al (2013) Age-dependent improvement in median and long-term survival in unselected population-based nordic registries of patients with synchronous metastatic colorectal cancer. Ann Oncol 24:2354–2360. https://doi.org/10.1093/annonc/mdt197 - DOI - PubMed
    1. Cheeseman SL, Joel SP, Chester JD et al (2002) A “modified de Gramont” regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancer. Br J Cancer 87:393–399. https://doi.org/10.1038/sj.bjc.6600467 - DOI - PubMed - PMC
    1. Falcone A, Ricci S, Brunetti I et al (2007) Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico No. J Clin Oncol Off J Am Soc Clin Oncol 25:1670–1676. https://doi.org/10.1200/JCO.2006.09.0928 - DOI
    1. United Nations, Department of economic and social affairs PD (2019) World population prospects 2019: Volume II: Demographic profiles

Publication types

LinkOut - more resources